← All stocks

Arteris, Inc.

AIP Mostly scheduled
CIK 0001667011 #2438 in the set updated 17 Sep 2026
Bought (120 mo)
$18.75
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$139.45M
$123.23M on a plan · $10.37M straight out of an exercise
Sold at will
$5.85M
82 of 531 sales
Net
−$139.45M
−$5.85M against sales at will

By person

15 insiders · 537 transactions
765×

K. Charles Janac holds 765 times base salary in stock. $365.17M of shares against $477.00K in salary for 2025.

Salary from the company's own proxy. The shares are what K. Charles Janac last reported holding, valued at $21.75, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
JANAC K CHARLES
President and CEO
$49.19M (125) scheduled
−$49.19M
16,789,542
34.16%
$365.17M
−8.9%
Bayview Legacy, LLC entity
10% owner
$40.51M (41) scheduled
−$40.51M
16,558,142
33.69%
$360.14M
−7.4%
RAZA SAIYED ATIQ
Director
$19.59M (33) scheduled
−$19.59M
4,703
0.0096%
$102.29K
−99.4%
Hawkins Nicholas B.
VP and Chief Financial Officer
$11.14M (98) scheduled
−$11.14M
95,666
0.1946%
$2.08M
−59.2%
Moll Laurent R
Chief Operating Officer
$7.50M (92) scheduled
−$7.50M
212,478
0.4323%
$4.62M
−67.7%
Viana Antonio J
Director
$5.16M (20) scheduled
−$5.16M
69,324
0.1410%
$1.51M
−83.4%
Alpern Paul L
VP and General Counsel
$3.68M (106) scheduled
−$3.68M
70,733
0.1439%
$1.54M
Cantwell Wayne C
Director
$18.75 (1)
$2.17M (12)
−$2.17M
465,728
0.9475%
$10.13M
+19.5%
Chitkara Raman
Director
$375.81K (3) scheduled
−$375.81K
147,570
0.3002%
$3.21M
+123.6%
Geday Isabelle F
Director
$140.46K (1) scheduled
−$140.46K
121,213
0.2466%
$2.64M
+94.9%
Claussen Christian
Director
3,134,157
6.38%
$68.17M
Ventech Capital F entity
10% owner
3,127,907
6.36%
$68.03M
Sinha Saurabh
Chief Financial Officer
142,835
0.2906%
$3.11M
Munce Claudia F.
Director
106,764
0.2172%
$2.32M
Kunkel Joachim
Director
74,695
0.1520%
$1.62M

Nothing of that kind in this period.

What was left out

Form 4 filings counted 418
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 400
Sales straight out of an exercise 49
Sales at will 82
Transactions with no price 0
Shares from compensation/vesting 11,160,900
Sales filed before the plan box existed 23
History held since 29 Oct 2021